Expert Session: What Every Formulator Should Know about Nitrosamine Risk Formulation
Concerned about nitrosamine risk in your formulations?
Whether you're developing new formulations, managing regulatory requirements, or evaluating excipient suppliers, this free on-demand session provides actionable guidance to help you build safer, lower-risk formulations from the start.
In this session, you'll learn
- how nitrite levels in excipients contribute to nitrosamine formation
- manufacturing variables that can influence nitrite content and risk profiles
- low-nitrite excipient options and strategies to support compliance efforts
- practical insights for designing formulations with nitrosamine risk mitigation in mind
Our expert
Sheila Puspasari is the Technical Manager for North America at DFE Pharma, with 13 years of experience in the pharmaceutical industry driving formulation development, scale-up, and tech transfer through to successful commercialization.
Recommended for
Formulation scientists, pharmaceutical developers, R&D teams, QA/QC professionals, regulatory affairs specialists, and anyone responsible for managing nitrosamine risk and ensuring compliance throughout the drug development lifecycle.
Why Watch?
- Explore opportunities to reduce nitrosamines in your formulation
- Learn practical risk-based approaches used by manufacturers